Trafalgar International, Inc. (GCAN)
OTCMKTS · Delayed Price · Currency is USD
0.3998
0.00 (0.00%)
At close: Sep 15, 2026
Trafalgar International Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
397.55K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 12.63K | -35.41K | -73.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 373.80M |
| Petros Pharmaceuticals | 5.11M |
| Demand Brands | 165.00K |
| Sky Century Investment | 126.22K |
| Neutra | 66.07K |
| ViaDerma | 44.69K |
| Green Rain Energy Holdings | 2.63K |
| Fifty 1 Labs | 47.00 |
Trafalgar International News
- 4 weeks ago - Trafalgar International Launches U.S. Public Company Platform for Financial Services and Strategic Investment - PRNewsWire
- 9 months ago - GCANRx Announces Relisting To OTCQB Market Tier - GlobeNewsWire
- 1 year ago - GCANRx Announces Uplisting to New Market Tier - GlobeNewsWire
- 1 year ago - GCAN to Explore Strategic Alternatives in Artificial Intelligence and Quantum Computing - GlobeNewsWire
- 2 years ago - GCANRx Announces Completion of Preclinical Study for Neuropsychiatric Cannabinoid Therapy - GlobeNewsWire
- 2 years ago - GCANRx Featured in American Journal of Endocannabinoid Medicine - GlobeNewsWire
- 3 years ago - GCANRx Announces Approval of Phase II Clinical Trial to Treat Autism Related Spectrum Disorders - GlobeNewsWire
- 3 years ago - GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders - GlobeNewsWire